Insider Trading in Focus: HCP Inc (HCP)

HCP Inc (HCP) insider has recently participated in insider trading activity. Executive Vice President, Kowalske Darren A bought 3,822 shares for $99,831via one transaction Feb 11. Another notable insider trading was done by Lu Lihpang on Feb 11, who is the Executive Vice President of the company. The insider acquired 200 shares at an average price of $26.01. Following this sale, this insider’s stake in the company comprises 29,790 shares, priced at $781689.6 as of Friday. Lu Lihpang also bought 800 shares for $21,772 through one transaction Feb 10. Moreover, An insider buying of 25,000 shares was carried out by MARTIN LAURALEE, President and CEO at the company, on Feb 11. Following the transaction, the insider now owns 252,223 shares in total.

The stock has experienced a total of 59 insider trades in the past three months. These trades include 42 sell activities and 17 buy trades. Furthermore, over the past 12 months, the stock was traded 88 times by insiders. In 57 of these trades, the insider was a seller while an employee of the company was the buyer in thirty one instances.

HCP Inc (HCP) on February 9, 2016 announced results for the quarter and year ended December 31, 2015.

FOURTH QUARTER 2015 AND RECENT HIGHLIGHTS

• FFO as adjusted and FAD per share increased year-over-year by 1% to $0.80 and 2% to $0.67, respectively; FFO per share and EPS were ($0.99) and ($1.29), respectively (see “HCR ManorCare Update” on page 3)


• Raised $1.1 billion from capital recycling and financing activities, including $600 million of 4.0% senior unsecured notes that paid down 36% of 2016 debt maturities


• Completed $208 million of investment transactions


• Leased 911,000 sq. ft. in our life science and medical office (“MOB”) portfolios, bringing occupancy to 98.2% and 91.9%, respectively


• Pre-leased half of Phase I of The Cove life science development, and commenced $185 million development of Phase II, adding two Class A life science buildings representing 230,000 sq. ft.


• Jim Mercer retired from HCP as General Counsel on February 5, 2016; we thank Jim for his five years of contributions and commitment to HCP; named Troy McHenry as HCP’s new General Counsel


• Named NAREIT’s 2015 Healthcare Leader in the Light Award winner for sustainability achievements

FULL YEAR 2015 HIGHLIGHTS

• FFO as adjusted and FAD per share increased year-over-year by 4% to $3.16 and 6% to $2.72, respectively; FFO per share and EPS were ($0.02) and ($1.21), respectively


• Completed $2.1 billion of accretive investments, including:


• $1.1 billion in private pay senior housing, led by the $847 million acquisition of Chartwell’s portfolio


• $700 million expansion in our life science and MOB office platform, including a new $225 million institutional joint venture with Morgan Stanley owning an on-campus MOB portfolio, and $177 million Class A life science development of The Cove Phase I


• $278 million increase in our international investments, expanding our U.K. care home portfolio


• Raised $3 billion from financing and capital recycling activities, including $2.3 billion of debt at a blended rate of 3.5%


• Selling 50 HCR ManorCare (“HCRMC”) non-strategic assets with expected proceeds of $350 million (80% received to date)


• Executed 3.2 million sq. ft. of leasing in our life science and MOB portfolios


• Welcomed Justin Hutchens as Chief Investment Officer – Senior Housing and Care


• Named to the Dow Jones Sustainability North America Index for the third consecutive year and the Dow Jones Sustainability World Index for the first time